ReviewGastro hep advances2026
Assessment of Bowel Urgency in Ulcerative Colitis: Current Measures and Future Directions.
Review in Gastro hep advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bowel urgency (BU), a burdensome ulcerative colitis (UC) symptom, impacts quality of life. It is associated with higher levels of disease severity, corticosteroid use, hospitalization, and colectomy. Despite its prevalence and clinical significance, BU is underassessed in clinical practice and infrequently included as a clinical trial end point. This review evaluates the strengths and limitations of available patient-reported outcome (PRO) measures assessing BU in UC to inform future directions for its assessment. A literature review was conducted using PubMed, Google Scholar, and Embase to identify publications through October 31, 2024, using the key terms "ulcerative colitis assessment" and "bowel urgency." Publications assessing BU in UC using PRO scales developed according to Food and Drug Administration guidance were included. Five tools met the inclusion criteria. The Urgency Numeric Rating Scale provides a simple and time-efficient tool for clinical use, while multi-item tools such as the Symptoms and Impacts Questionnaire for Ulcerative Colitis and the Ulcerative Colitis-Symptom Questionnaire include comprehensive symptom tracking but impose greater burdens for clinical practice. Diary-based tools, including the Ulcerative Colitis-Patient-Reported Outcomes/Signs and Symptoms Diary and Patient-Reported Outcomes-Ulcerative Colitis Diary, allow detailed symptom monitoring in clinical trials but are less practical for routine clinical use. Some dimensions of BU are missing from the tools reviewed. Incorporating validated BU measurement into routine clinical care and research is essential for advancing patient-centered, comprehensive disease management and improving outcomes in patients with UC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.